scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0165-5728(02)00224-2 |
P698 | PubMed publication ID | 12225904 |
P50 | author | Clara M. Pelfrey | Q70849817 |
P2093 | author name string | Jar-Chi Lee | |
Richard A Rudick | |||
Anne C Cotleur | |||
P2860 | cites work | Structure of the human class I histocompatibility antigen, HLA-A2 | Q24297966 |
Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains | Q31838764 | ||
Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. | Q34293044 | ||
Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis | Q35159951 | ||
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. | Q35372676 | ||
Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand | Q35957193 | ||
T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes | Q36229970 | ||
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease | Q36364080 | ||
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions | Q36365596 | ||
IL-12 unmasks latent autoimmune disease in resistant mice | Q36367147 | ||
Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis | Q36368128 | ||
Endogenous myelin basic protein inactivates the high avidity T cell repertoire | Q36401074 | ||
Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein | Q37360410 | ||
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system | Q40796002 | ||
Genetic control of the CD4/CD8 T-cell ratio in humans. | Q41653812 | ||
Gender-dependent IL-12 secretion by APC is regulated by IL-10. | Q41740131 | ||
Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production | Q43699058 | ||
Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis | Q43763813 | ||
Sex-dependent, early cytokine production by NK-like spleen cells following infection with the D variant of encephalomyocarditis virus (EMCV-D). | Q45844721 | ||
Increased release of interleukin-12p40 in MS: association with intracerebral inflammation | Q48390502 | ||
Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. | Q52028233 | ||
Strategies for epitope analysis using peptide synthesis. | Q54133512 | ||
A gender gap in autoimmunity. | Q55032884 | ||
Increased 16α-Hydroxylation of Estradiol in Systemic Lupus Erythematosus* | Q57536020 | ||
In vivo competition between self peptides and foreign antigens in T-cell activation | Q59065328 | ||
Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? | Q67236213 | ||
Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function | Q70372027 | ||
Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation | Q70407740 | ||
Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD II. Importance of one major autosomal locus and additional sexual influences | Q70474649 | ||
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis | Q71664308 | ||
Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis | Q72092884 | ||
Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization | Q72427037 | ||
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group | Q73187378 | ||
Immunomodulatory effects of interferon beta-1a in multiple sclerosis | Q73276261 | ||
Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production | Q74027273 | ||
Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo | Q74121880 | ||
In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis | Q74575052 | ||
P433 | issue | 1-2 | |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 211-223 | |
P577 | publication date | 2002-09-01 | |
P1433 | published in | Journal of Neuroimmunology | Q15716691 |
P1476 | title | Sex differences in cytokine responses to myelin peptides in multiple sclerosis | |
P478 | volume | 130 |
Q92445909 | "Bridging the Gap" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era |
Q55357541 | Androgen-Induced Immunosuppression. |
Q27012075 | Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis |
Q35513272 | Blood pressure normalization post-jugular venous balloon angioplasty |
Q40543886 | EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature. |
Q28296175 | Exercise and multiple sclerosis |
Q39287039 | Expanding Diversity and Common Goal of Regulatory T and B Cells. I: Origin, Phenotype, Mechanisms |
Q37209917 | Gender and sex hormones in multiple sclerosis pathology and therapy. |
Q34040802 | Gender differences in autoimmune disease |
Q36511926 | Gender differences in neurological disease: role of estrogens and cytokines |
Q81326731 | IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis |
Q33827668 | Interplay of hormones and p53 in modulating gender dimorphism of subventricular zone cell number. |
Q55347930 | Is there a link between inflammation and fatigue in multiple sclerosis? |
Q30427052 | Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year |
Q36449562 | Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens |
Q91853720 | Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes |
Q36229701 | Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity |
Q36066219 | Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. |
Q37262802 | Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice |
Q34460512 | Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs |
Q50146321 | Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression |
Q34498866 | Sex differences in autoimmune diseases |
Q58563707 | Sex differences in autoimmune disorders of the central nervous system |
Q44397694 | Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients |
Q91123514 | Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role |
Q31037759 | Sex hormones: a role in the control of multiple sclerosis? |
Q35619427 | Sex-related factors in multiple sclerosis susceptibility and progression |
Q37518569 | Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection. |
Q35235610 | TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity |
Q39015338 | The importance of studying sex differences in disease: The example of multiple sclerosis |
Q90013058 | Therapeutic and immunological interventions in primary biliary cholangitis: from mouse models to humans |
Q55387422 | Toward solving the etiological mystery of primary biliary cholangitis. |
Search more.